CEO and Founder, Hertility
Dr Helen O'Neill
Dr Helen O’Neill is CEO and Founder of Hertility, an award-winning digital health company shaping the future of reproductive healthcare by pioneering unique diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause.
Dr Helen O’Neill is a Tenured Lecturer in Reproductive and Molecular Genetics at the Institute for Women’s Health, University College London. She has a Master of Science in Prenatal Genetics and Fetal Medicine, a PhD in Stem Cell Biology and Developmental Genetics and has spent the last 15 years researching genetics, fertility and women’s health.